AFLIBERCEPT intravitreal injection (Eylea®▼) for branch retinal vein occlusion - Pan Mersey APC Skip to main content Help with accessibility Skip to main navigation

AFLIBERCEPT intravitreal injection (Eylea®▼) for branch retinal vein occlusion

Last Updated: 02 November 2016

Body System: Eye

Red

The Pan Mersey Area Prescribing Committee recommends the prescribing of AFLIBERCEPT intravitreal injection (Eylea®▼), by ophthalmologists only, for treating visual impairment caused by macular oedema after branch retinal vein occlusion in accordance with NICE TA409.